Symbols

European healthcare stocks ended a run of gains in October, raising concerns for drugmakers like Novo Nordisk (NVO.US)

Generated by AI AgentMarket Intel

Monday, Sep 30, 2024 6:50 am ET1min read

European healthcare stocks' longest winning streak since March 2010 is set to end as investors fret over Novo Nordisk's (NVO.US) upcoming third-quarter results and updates on experimental drugs from AstraZeneca (AZN.US) and Roche (RHHBY.US), data show. The Stoxx 600 healthcare index has fallen 6.1% this month, ending a 10-month winning streak, with Novo Nordisk, AstraZeneca and Roche accounting for about 90% of the decline since the start of the month.

Market Intel

Global insights driving the market strategies of tomorrow.

Latest Articles

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments

﻿

Add a public comment...

No comments yet

AInvest
PRO

Editorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process. While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context. Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue